This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Friday's Small-Cap Winners & Losers

Baldor Electric (BEZ) rose after the motor maker beat Wall Street's second-quarter earnings expectations. The company posted earnings of $12.4 million, or 38 cents a share, up from $9.7 million, or 29 cents a share, a year ago. Sales grew 15% to $205.6 million. Analysts polled by Thomson Financial had expected earnings of 36 cents a share.

The company said in a news release that it believes business for the rest of the year "looks strong." While shipments were up 15% during the quarter, the company said, incoming order rates increased 20%. Shares gained $1.82, or 6.4%, to $30.22.

LHC Group (LHCG - Get Report), a provider of post-acute health care services, was climbing following word it priced a public offering of 4 million shares at $19.25 each. Of the total, the company is offering 1 million and stockholders are selling 3 million.

Shares of LHC were up $1.69, or 8.7%, to $21.10.

Chemed (CHE - Get Report) plummeted after the company, which provides hospice programs and also owns the plumbing-services business Roto-Rooter, said second-quarter earnings would miss expectations. Chemed also lowered its full-year guidance.

The company expects second-quarter earnings of 48 cents a share, with revenue up 10% to $250 million. Wall Street is looking for earnings of 54 cents a share on $255 million in revenue. Chemed cut its guidance for full-year earnings from continuing operations to a range of $2.18 to $2.25 a share, excluding one-time items. The company had earlier forecast earnings of $2.20 to $2.35 a share. Analysts are looking for $2.27. Shares of Chemed sank $9.64, or 19.1%, to $40.86.

eResearch Technology (ERES) stumbled after the clinical trial-consulting company lowered its second-quarter guidance. The company expects revenue of about $22.5 million, or 10% below the low end of its previous forecast of $25 million to $27 million. The consensus analyst target is $25.7 million.

eResearch is reassessing its 2006 guidance and plans to provide an update in connection with the second-quarter conference call. eResearch is scheduled to report second-quarter results Aug. 3. Shares fell 57 cents, or 6.7%, to $7.98.

Rocky Brands (RCKY - Get Report) slid after the footwear and apparel maker said it expects to post a loss for the second quarter. Rocky Brands projected a second-quarter loss of 5 cents to 10 cents a share, sharply worse than analysts' estimate of 45 cents a share. A year earlier, the company recorded earnings of 50 cents a share.

The company estimated sales of about $57 million, down from $65.5 million a year ago. Rocky Brands is scheduled to report its second-quarter results July 27. Shares fell $9.47, or 42.5%, to $12.82.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
CHE $119.43 0.85%
LHCG $30.53 1.30%
RCKY $21.19 -1.44%
AAPL $125.01 -0.63%
FB $78.10 0.70%

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs